Factor V Leiden homozygous mutation: Recurrent venous thromboembolism during periods of discontinuation of anticoagulant therapy. JHSCI [Internet]. 2021 Sep. 16 [cited 2024 Nov. 22];11(2):137-41. Available from: https://jhsci.ba/ojs/index.php/jhsci/article/view/1283